These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 16678544

  • 1. Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin.
    Igel M, Arnold KA, Niemi M, Hofmann U, Schwab M, Lütjohann D, von Bergmann K, Eichelbaum M, Kivistö KT.
    Clin Pharmacol Ther; 2006 May; 79(5):419-26. PubMed ID: 16678544
    [Abstract] [Full Text] [Related]

  • 2. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
    Niemi M, Pasanen MK, Neuvonen PJ.
    Clin Pharmacol Ther; 2006 Oct; 80(4):356-66. PubMed ID: 17015053
    [Abstract] [Full Text] [Related]

  • 3. Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.
    Kivistö KT, Niemi M.
    Pharm Res; 2007 Feb; 24(2):239-47. PubMed ID: 17177112
    [Abstract] [Full Text] [Related]

  • 4. Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril.
    Maeda K, Ieiri I, Yasuda K, Fujino A, Fujiwara H, Otsubo K, Hirano M, Watanabe T, Kitamura Y, Kusuhara H, Sugiyama Y.
    Clin Pharmacol Ther; 2006 May; 79(5):427-39. PubMed ID: 16678545
    [Abstract] [Full Text] [Related]

  • 5. Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatin.
    Aquilante CL, Kiser JJ, Anderson PL, Christians U, Kosmiski LA, Daily EB, Hoffman KL, Hopley CW, Predhomme JA, Schniedewind B, Sidhom MS.
    J Clin Pharmacol; 2012 Nov; 52(11):1725-38. PubMed ID: 22174437
    [Abstract] [Full Text] [Related]

  • 6. Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels.
    Gerloff T, Schaefer M, Mwinyi J, Johne A, Sudhop T, Lütjohann D, Roots I, von Bergmann K.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):45-50. PubMed ID: 16568260
    [Abstract] [Full Text] [Related]

  • 7. Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics.
    Mwinyi J, Johne A, Bauer S, Roots I, Gerloff T.
    Clin Pharmacol Ther; 2004 May; 75(5):415-21. PubMed ID: 15116054
    [Abstract] [Full Text] [Related]

  • 8. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers.
    Daka A, Dimovski A, Kapedanovska A, Vavlukis M, Eftimov A, Labachevski N, Jakjovski K, Geshkovska MN, Nebija D, Mladenovska K.
    Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210
    [Abstract] [Full Text] [Related]

  • 9. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
    Pasanen MK, Neuvonen M, Neuvonen PJ, Niemi M.
    Pharmacogenet Genomics; 2006 Dec; 16(12):873-9. PubMed ID: 17108811
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.
    Hedman M, Antikainen M, Holmberg C, Neuvonen M, Eichelbaum M, Kivistö KT, Neuvonen PJ, Niemi M.
    Br J Clin Pharmacol; 2006 Jun; 61(6):706-15. PubMed ID: 16722833
    [Abstract] [Full Text] [Related]

  • 11. Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate.
    Pasanen MK, Miettinen TA, Gylling H, Neuvonen PJ, Niemi M.
    Pharmacogenet Genomics; 2008 Oct; 18(10):921-6. PubMed ID: 18794729
    [Abstract] [Full Text] [Related]

  • 12. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.
    Niemi M, Arnold KA, Backman JT, Pasanen MK, Gödtel-Armbrust U, Wojnowski L, Zanger UM, Neuvonen PJ, Eichelbaum M, Kivistö KT, Lang T.
    Pharmacogenet Genomics; 2006 Nov; 16(11):801-8. PubMed ID: 17047488
    [Abstract] [Full Text] [Related]

  • 13. The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15.
    Deng JW, Song IS, Shin HJ, Yeo CW, Cho DY, Shon JH, Shin JG.
    Pharmacogenet Genomics; 2008 May; 18(5):424-33. PubMed ID: 18408565
    [Abstract] [Full Text] [Related]

  • 14. SLCO1B1 521T-->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients.
    Zhang W, Chen BL, Ozdemir V, He YJ, Zhou G, Peng DD, Deng S, Xie QY, Xie W, Xu LY, Wang LC, Fan L, Wang A, Zhou HH.
    Br J Clin Pharmacol; 2007 Sep; 64(3):346-52. PubMed ID: 17439540
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17.
    Niemi M, Neuvonen PJ, Hofmann U, Backman JT, Schwab M, Lütjohann D, von Bergmann K, Eichelbaum M, Kivistö KT.
    Pharmacogenet Genomics; 2005 May; 15(5):303-9. PubMed ID: 15864131
    [Abstract] [Full Text] [Related]

  • 16. Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics.
    Becquemont L, Neuvonen M, Verstuyft C, Jaillon P, Letierce A, Neuvonen PJ, Funck-Brentano C.
    Clin Pharmacol Ther; 2007 May; 81(5):679-84. PubMed ID: 17301736
    [Abstract] [Full Text] [Related]

  • 17. Influence of SLCO1B1 polymorphisms on atorvastatin efficacy and safety in Macedonian subjects.
    Mladenovska K, Grapci AD, Vavlukis M, Kapedanovska A, Eftimov A, Geshkovska NM, Nebija D, Dimovski AJ.
    Pharmazie; 2017 May 01; 72(5):288-295. PubMed ID: 29441875
    [Abstract] [Full Text] [Related]

  • 18. Impact of genetic variation in the SLCO1B1 gene on statin efficacy in low-density lipoprotein cholesterol-lowering therapy.
    Couvert P, Chapman MJ, Carrié A.
    Pharmacogenomics; 2011 Feb 01; 12(2):137-9. PubMed ID: 21332305
    [No Abstract] [Full Text] [Related]

  • 19. SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers.
    Ieiri I, Suwannakul S, Maeda K, Uchimaru H, Hashimoto K, Kimura M, Fujino H, Hirano M, Kusuhara H, Irie S, Higuchi S, Sugiyama Y.
    Clin Pharmacol Ther; 2007 Nov 01; 82(5):541-7. PubMed ID: 17460607
    [Abstract] [Full Text] [Related]

  • 20. Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly.
    Akao H, Polisecki E, Kajinami K, Trompet S, Robertson M, Ford I, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J, Packard C, Buckley BM, Schaefer EJ.
    Atherosclerosis; 2012 Feb 01; 220(2):413-7. PubMed ID: 22189199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.